Furthermore, myocarditis was also reported in a patient with multiple myeloma who was treated with an immunomodulatory drug (lenalidomide-dexamethasone) combined with an anti-PD-1 inhibitor (pembrolizumab) [38]. The gene discussed is PDCD1; the disease is plasma cell myeloma.